iTeos Therapeutics
Biotechnology ResearchView the employees at
iTeos Therapeutics-
Erica Houthuys Director - Project Head EOS-984 @ iTeos Therapeutics
-
Belgium
-
Rising Star
Robert Gardner Senior Medical Writer-
Banbury, England, United Kingdom
-
Rising Star
Hélène Busser Post doctoral Scientist at iTeos Therapeutics SA-
Charleroi, Walloon Region, Belgium
-
Top 10%
Adriana Maguire Sullivan, CPA Global Controller, VP at iTeos Therapeutics-
Concord, Massachusetts, United States
-
Top 10%
Overview
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT:CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
-